Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literatu...
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Atezolizumab is a monoclonal antibody that targets programmed death ligand-1. Treatments with this drug may cause immune-related adverse events by creating an exaggerated inflammatory response. The most common side effects are fatigue, rash, and gastrointestinal symptoms. Cases of central nervous system toxicity such as encephalitis and encephalopa...
Alternative Titles
Full title
Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_86633c07a6014ac19c816b38be251ad3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_86633c07a6014ac19c816b38be251ad3
Other Identifiers
ISSN
2050-313X
E-ISSN
2050-313X
DOI
10.1177/2050313X18792422
